Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Arlington Towers

Sep 20, 2022 7:00 AM - Sep 21, 2022 3:00 PM

950 N Stafford St., Arlington, VA 22203-1813, USA

Biosimilars Conference

Convening Professionals in Biosimilar Development to Discuss the Challenges of Today and the Possibilities of Tomorrow

Session 3a: Roadblocks and Disparities in Access of Biologics

Session Chair(s)

Tiffany  Fletcher, MA

Tiffany Fletcher, MA

Head of Global Access Policy

Viatris, United States

Juliana Marguerite Reed, MS

Juliana Marguerite Reed, MS

Executive Director

The Biosimilars Forum, United States

This session will discuss access of biologic treatments in different geographies prior to the introduction of biosimilars and what impact biosimilars have made in conquering disparities in access to medicines and improving health equity of patients. The cost burden of chronic disease continues to grow while healthcare budgets are further constrained. Biologics treat some of the most complex diseases. In the US, for example, 40% of all drug spending if for biologic drugs, yet biologics only account for 2% of all prescriptions. Cost is one factor that contributes to disparities in access. This session will discuss access of biologic treatments in different geographies prior to the introduction of biosimilars and what impact biosimilars have made in conquering disparities in access to medicines and improving health equity of patients.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify the differences in patient access to biologics/biosimilars by region
  • Identify how biosimilars have improved health equity and access to treatment for patients
  • Identify how different regions implemented policies to increase patient access to these medicines

Speaker(s)

Murray  Aitken, MBA

Speaker

Murray Aitken, MBA

IQVIA Institute for Human Data Science, United States

Executive Director

Anna  Hyde, MA

Speaker

Anna Hyde, MA

Arthritis Foundation, United States

Vice President of Advocacy & Access

Terry  Wilcox

Terry Wilcox

Patients Rising, United States

Co-Founder and CEO

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.